(Q50749756)

18 March 2018

title

Longitudinal progression of fracture prevalence through a population of postmenopausal women with osteoporosis. (English)

1 reference

18 March 2018

0 references

1 reference

Robert Lindsay

1

1 reference

18 March 2018

Simon Pack

series ordinal

2

1 reference

18 March 2018

Zhengqing Li

series ordinal

3

1 reference

18 March 2018

language of work or name

English

0 references

publication date

28 September 2004

1 reference

18 March 2018

Osteoporosis International

published in

1 reference

18 March 2018

volume

16

1 reference

18 March 2018

issue

3

1 reference

18 March 2018

page(s)

306-312

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s00198-004-1691-5

exact match

0 references

cites work

Epidemiology of vertebral fractures in women

1 reference

12 December 2020

Clinical consequences of vertebral fractures

1 reference

12 December 2020

The clinical impact of vertebral fractures: quality of life in women with osteoporosis

1 reference

12 December 2020

Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: a 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Pre-existing fractures and bone mass predict vertebral fracture incidence in women

1 reference

12 December 2020

Risedronate reduces the risk of first vertebral fracture in osteoporotic women

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Hormone replacement therapy in postmenopausal women: urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density

1 reference

12 December 2020

BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

1 reference

12 December 2020

Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study

1 reference

12 December 2020

Risk of new vertebral fracture in the year following a fracture

1 reference

12 December 2020

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989

1 reference

12 December 2020

Association of osteoporotic vertebral compression fractures with impaired functional status

1 reference

12 December 2020

Perspective. How many women have osteoporosis?

1 reference

12 December 2020

Long-term fracture prediction by bone mineral assessed at different skeletal sites

1 reference

12 December 2020

Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

Spatial relationships between prevalent and incident spine fractures

1 reference

12 December 2020

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

1 reference

12 December 2020

Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS).

1 reference

12 December 2020

Lifetime and five-year age-specific risks of first and subsequent osteoporotic fractures in postmenopausal women.

1 reference

12 December 2020

The worldwide problem of osteoporosis: insights afforded by epidemiology

1 reference

12 December 2020

10.1007/S00198-004-1691-5

Identifiers

DOI

1 reference

18 March 2018

PubMed ID

15455193

1 reference

18 March 2018